Pancreatitis During Treatment with Liraglutide
No abstract available.
Image: San Camillo Hospital. Rome, Italy
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-45. [PMID 7249508]
Pinelli NR, Hurren KM. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Pharmacother 2011; 45:850-60. [PMID 21730278]
Noel RA, Braun DK, Patterson RE, et al. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care 2009; 32:834-8. [PMID 19208917]
Parks M, Rosebraugh C. Weighing risks and benefits of liraglutide. The FDA’s review of a new antidiabetic therapy. N Engl J Med 2010; 362:774-7. [PMID 20164475]
Knezevich E, Crnic T, Kershaw S, et al. Liraglutide-associated acute pancreatitis. Am J Health Syst Pharm 2012; 69:386-9. [PMID 22345417]
Lee PH, Stockton MD, Franks AS. Acute pancreatitis associated with liraglutide. Ann Pharmacother 2011; 45:e22. [PMID 21487080]
Koehler JA, Baggio LL, Lamont BJ, et al. Glucagon-like peptide-1- receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice. Diabetes 2009; 58:2148-61. [PMID 19509017]
Nyborg NC, Mølck AM, Madsen LW, et al. The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species. Diabetes 2012; 61:1243-9. [PMID 22338093]
Copyright (c) 2014 Giuseppe Famularo, Laura Gasbarrone, Giovanni Minisola
This work is licensed under a Creative Commons Attribution 4.0 International License.As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.